19th Annual · February 2021 · Virtual
2021
- 34 faculty
- 6 recordings
- 10:00 am
- 10:10
10:20
Session 1
Utility of Blood Biomarkers in the Diagnosis of Pre-Clinical and Clinical AD
Chair: Henrik Zetterberg, MD, PhDUniversity of Gothenburg
- 10:20Session Overview
- 10:25Keynote Recent Developments in the Clinical Application of Blood Biomarkers for Screening and Diagnosis of AD and other Neurodegenerative Diseases
- 11:00Utility of Blood Biomarkers for AD Diagnosis – Experience from the SEABIRD Study
- 11:20Utility of Blood Biomarkers for AD Diagnosis – Experience from the BioFinder Study
- 11:40Utility of Blood Biomarkers for AD Diagnosis – Experience from the Rotterdam Study
- 12:00 pmUtility of Blood Biomarkers for Distinguishing between AD and FTLD
- 12:20Panel Discussion/Q&A
- 12:45SHORT PRESENTATIONS
- 1:15Break
1:30
Session 2
Sensory Disorders (Olfaction Hearing and Visual Deficits) in Preclinical AD and Early MCI
Chair: Shannon Risacher, PhDIndiana University
- 1:30Session Overview
- 1:35Keynote Multidomain Sensory Measures as Biomarkers of Preclinical and Prodromal AD
- 2:00Association of Visual Acuity to Cognitive Impairment and Cognitive Decline
- 2:20Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer’s Disease
- 2:40Association of Olfactory Identification Deficits with Amyloid, Tau and Inflammatory Pathology in the Brain
- 3:00Delivering Novel Neuro Retinal Biomarkers for Early Diagnosis of Alzheimer's Disease
- 3:20Age-related Sensory Deficits and Their Consequences
- 3:40Panel Discussion/Q&A
- 4:00SHORT PRESENTATIONS
- 4:30END OF DAY 1
10:00 am
Vascular MCI
Chair: Sandra Black, MDSunnybrook Research Institute
- 10:00
- 10:05Keynote Neurovascular Coupling in Health and Disease - The Grey Zone between Vascular Cognitive Impairment and MCI-AD
- 10:40
- 11:00Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease
- 11:20Relevance of Brain Lesion Location for Cognition in Vascular Mild Cognitive Impairment
- 11:40The Complex Profiles of Cerebrovascular Disease Pathologies in the Aging Brain and Their Relationship with Cognitive Decline
- 12:00 pmAssociation of Perivascular Space Enlargement and Cognitive Impairment
- 12:20Panel Discussion/Q&A
- 12:45SHORT PRESENTATIONS
- 1:15END OF SYMPOSIUM
- 1:30 pm
- 1:35Keynote Locus of Control and Cognitive Performance in Adulthood
- 2:10Cognitive and Neuroimaging Evidence for ADHD as a Phenotypic Mimic of Prodromal Dementia
- 2:30Stressful Events and Racial Disparities in Cognition
- 2:50Break
- 3:00Relationship between Cognitive Performance and Measures of Neurodegeneration among Hispanic and White Non-Hispanic Individuals
- 3:20Cognitive Assessment and Mild Cognitive Impairment among Diverse Latinos
- 3:40Pseudodementia, Pseudopseudodementia and Pseudodepression
- 4:00Panel Discussion/Q&A
- 4:25
- 4:30SHORT PRESENTATIONS
- 5:00END OF WORKSHOP
- 1:30 pmIntroductory Notes and MCI Symposium and Workshop Highlights
- 1:45You asked, we answer! Top 5 FAQs(Top five questions posed through the registration form and answered by top researchers in the field)
- How can you distinguish between normal and abnormal cognitive aging using cognitive testing? Are the person’s age, education, cultural and emotional background important factors in determining how you make these distinctions?
- I have a family history of dementia – are there genetic risk factors for different forms of MCI and dementia which can be assessed through blood or saliva samples?
- I have been diagnosed with Alzheimer’s disease – where would I find the best resources?Keith GibsonAlzheimer’s Association Southeast Florida
- I have a history of anxiety and depression – do I have an increased risk for developing Mild Cognitive Impairment and Alzheimer’s disease? Does treatment of depression and anxiety affect the risk for developing MCI and Alzheimer’s?
- My mother has memory loss and has been diagnosed with MCI; are there ways to predict whether, and how quickly, it will progress to dementia?
- 2:00What treatments are available now?
- 2:10DiscussionModerators: Howard Chertkow, MD, Jeffrey Cummings, MD, ScD, Sterling Johnson, PhD, David Morgan, PhD
- 2:20
- 2:30DiscussionModerators: Howard Chertkow, MD, Jeffrey Cummings, MD, ScD, Sterling Johnson, PhD, David Morgan, PhD
- 2:40What is the impact of COVID19 on older adults and caregivers?
- 2:50DiscussionModerators: Howard Chertkow, MD, Jeffrey Cummings, MD, ScD, Sterling Johnson, PhD, David Morgan, PhD
- 3:00What are the top 5 things to do to promote brain health?
- 3:10DiscussionModerators: Howard Chertkow, MD, Jeffrey Cummings, MD, ScD, Sterling Johnson, PhD, David Morgan, PhD
- 3:20Concluding Remarks
- 3:30END OF FORUM
Programs, recordings and slides as published at the time. Slides and recordings appear only where speakers chose to share them. Affiliations are as of 2021.